Advertisement

Topics

Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)

2015-02-09 19:11:47 | BioPortfolio

Published on BioPortfolio: 2015-02-09T19:11:47-0500

Clinical Trials [930 Associated Clinical Trials listed on BioPortfolio]

MK0928 Study in Adult Patients With Primary Insomnia

A study to evaluate the efficacy, safety and tolerability of MK-0928 in Primary Insomnia.

Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia

A study to evaluate the efficacy, safety and tolerability of MK-0928 in Primary Insomnia.

Efficacy and Safety of MK0928 for Insomnia in Adults

The purpose of this trial is to study the safety and effectiveness of MK0928 for adults with insomnia.

Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED)

The purpose of the study is to test the safety and effectiveness of an Investigational Drug on insomnia in the elderly.

An Investigational Study of MK0928 in Adult Outpatients With Insomnia

The purpose of this study is to evaluate the safety and effectiveness of MK0928 for insomnia (a sleep disorder).

PubMed Articles [25692 Associated PubMed Articles listed on BioPortfolio]

Electroacupuncture for primary insomnia: Protocol for a systematic review and meta-analysis.

Insomnia is a highly widespread sleep disorder in the general population. Electroacupuncture (EA) has been widely received attention as a potential treatment for primary insomnia. However, few previou...

Insomnia: Will Medication Bring Rest?

Acute and chronic insomnia are common and difficult clinical problems that contribute to and are consequences of other mental and physical health problems. It is tempting to treat insomnia with medica...

Impact of group treatment for insomnia on daytime symptomatology: Analyses from a randomized controlled trial in primary care.

People typically seek primary health care for daytime symptoms and impairments they experience in association with their insomnia. However, few studies address the question of whether insomnia treatme...

Treatment Options for Insomnia in Schizophrenia: A Systematic Review.

Insomnia is a common feature of schizophrenia. Although several studies have been published about the influence of certain drugs on schizophrenia patients' sleep, there are no well-grounded recommenda...

Sleep profiles and CBT-I response in schizophrenia and related psychoses.

This study investigated sleep subtypes in schizophrenia, and their response to Cognitive Behavioural Therapy for Insomnia (CBT-I) treatment. Sleep profiling was conducted using latent class analysis o...

Medical and Biotech [MESH] Definitions

CHILDBIRTH at the end of a normal duration of PREGNANCY, between 37 to 40 weeks of gestation or about 280 days from the first day of the mother's last menstrual period.

An autosomal dominant disorder characterized by degeneration of the THALAMUS and progressive insomnia. It is caused by a mutation in the prion protein (PRIONS).

A hypnotic and sedative used in the treatment of INSOMNIA.

A benzodiazepine used in the treatment of anxiety, alcohol withdrawal, and insomnia.

The three approximately equal periods of a normal human PREGNANCY. Each trimester is about three months or 13 to 14 weeks in duration depending on the designation of the first day of gestation.

More From BioPortfolio on "Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)"

Advertisement
Quick Search
Advertisement
Advertisement

 

Searches Linking to this Trial